After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Disposition
Calculated transaction value
$3.74M

Fenimore Christopher R. EVP Finance CFO

Transaction date Aug 18, 2026
Public filing date Aug 20, 2026
Filing lag Filed 2 days later

REGN daily price context

Close on/before transaction
$810.24 Aug 18, 2026
First close after public filing
$834.04 Aug 21, 2026
30-day return after filing
-4.3% Through Sep 21, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
4,599 shares @ $813.47
SEC ownership
Direct
Transaction code
F
Form
4
Filing identifier
0001697422-26-000002
Filing cohort

Transactions in this filing

Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$6.14M
Buys / sales
0 / 0
Transactions reported in the same official filing
Issuer Transaction Traded Value
Regeneron Pharmaceuticals, Inc. REGN Current Disposition Aug 18, 2026 $3.74M
Regeneron Pharmaceuticals, Inc. REGN Exercise Aug 18, 2026 $2.4M
Regeneron Pharmaceuticals, Inc. REGN Exercise Aug 18, 2026 $0